SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Safeguard Scientifics SFE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: gdichaz who wrote (3370)8/21/1999 8:39:00 PM
From: Katherine Derbyshire  Read Replies (1) of 4467
 
>> Would hope that SFE management would give higher priority
to strengthening winners than helping the wounded survive.

Build on strength and sell the weak is a good general rule.

The danger is that SFE thinks of itself as a doctor who heals, as opposed to a
generator of winners. <<

But how do you tell which ones are the winners?

Going back to the medical analogy, you could start with identical twin babies, both born healthy and strong. If you feed one and don't feed the other, the neglected one will die. It takes 15-20 years or more to figure out whether one or both of them will succeed. Do you quit feeding one of them because he cries more than the other?

Baby companies grow up faster than baby humans, but they still all face a stage where they cry a lot and will die without management, capital, and all the other "food" uncle SFE provides.

All of this shows where the common analogy between SFE and a closed end mutual fund breaks down. The fund can't really influence the direction of the companies it buys, while SFE can. So you could view the premium (or discount) over NAV as the value of the private companies *plus* the value of SFE's expertise. Any statisticians out there have a good metric for that expertise?

Katherine
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext